FDA grants new indication for BRIVIACT for partial-onset seizures in patients 16 years and older with epilepsy. Ruby Khatun Khatun19 Sept 2017 9:24 AM ISTATLANTA and BRUSSELS: UCB announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for...
